Kim SH, Kim YS, Kim S, et al. - To compare dexmedetomidine’s impacts on postoperative bleeding following thyroidectomy, researchers performed randomized, double-blind, controlled trials in female patients (ASA I–II, aged 20 to 60 years). Randomization of patients to two groups was done. Nearly 15 min prior to the termination of the surgery, dexmedetomidine was given (0.6 µg/kg/h) without a loading dose in group D (n = 69), and normal saline was delivered in group S (n = 70) at the same infusion rate. A significantly lower incidence of severe cough was observed in group D vs in group S. A significantly lower emergence agitation in the postanesthetic care unit was noted in the group D vs in group S. Overall, it was inferred that dexmedetomidine can offer reduction of bleeding post-thyroidectomy by decreasing coughing and emergence agitation.